By leveraging the power of oxygen, these gelatin patches can act as effective tissue adhesives that accelerate the healing of wounds
Tag: disease control
Epigenetic signature for obesity found in study of twins
WSU study finds epigenetic signature in cheek cells of obese people, suggesting a biomarker test for obesity could be developed
The sunscreen paradox: McGill University researchers warn of ‘false sense of security’
Sunscreen is important, says Dr. Ivan Litvinov, but it is also the least effective way to protect your skin when compared to sun protective clothing and sun avoidance
Post-COVID condition is not linked to ongoing infection or active brain damage
Post COVID-19 condition does not appear to be linked to direct viral invasion of the brain or active brain damage. This has been shown by a study at the University of Gothenburg. Searching for abnormal biomarkers among the participants yielded no hits in either blood or cerebrospinal fluid samples
Study finds SARS-CoV-2-associated sepsis was more common, deadly than previously thought
Using data from Mass General Brigham’s electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic
$8.7M to vector-borne disease center funds training, evaluation
To help respond to emerging and established vector-borne threats, the Northeast Regional Center for Excellence in Vector-Borne Diseases (NEVBD), led by Cornell, has received a five-year, $8.7 million award from the Centers for Disease Control and Prevention (CDC) to train and educate current and future vector-borne disease professionals and to evaluate the effectiveness of community and regional prevention strategies.
Kenyan hospital visits linked to increased exposure to antibiotic-resistant bacteria
Kenyan patients who spend more than three days in the nation’s hospitals are more likely to harbor a form of bacteria resistant to one of the most widely used antibiotic classes, according to a recent study led by Washington State University.
Mpox (Monkeypox): We Must Not Let Our Guard Down
This month, the World Health Organization declared an end to the Mpox emergency and urged a transition to a “robust, proactive and sustainable” response to Mpox.
Study shows hospital policy allowing nurses to initiate C. difficile testing could reduce infection spread and associated morbidity
A new study published today in the American Journal of Infection Control (AJIC) suggests that allowing bedside nurses to independently order testing for C. difficile significantly decreased the amount of time to receive test results as compared to requiring physician approval.
The potential and challenges of mucosal COVID-19 vaccines
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.
UNLV, SNWA Study Makes Case for Candida Auris Wastewater Surveillance
A rapid spike in cases of a potentially deadly, drug-resistant fungus has concerned public health officials across the nation. But a team of Southern Nevada researchers hope their new study applying wastewater surveillance can help health officials get a step ahead of this emerging global public health threat.
Hidden ‘super spreaders’ spur dengue fever transmission
For mosquito-borne diseases such as dengue fever, the abundance of the insects in places where people gather has long served as the main barometer for infection risk. A new study, however, suggests that the number of “hidden” infections tied to a place, or cases of infected people who show no symptoms, is the key indicator for dengue risk.
Heart-healthy lifestyle linked to a longer life, free of chronic health conditions
Two new studies by related research groups have found that adults who live a heart-healthy lifestyle, as measured by the American Heart Association’s Life’s Essential 8 (LE8) cardiovascular health scoring, tend to live longer lives free of chronic disease.
Review of studies finds disparity in presumptive chlamydia and gonorrhea treatment rates despite CDC guidelines
A Regenstrief Institute-led review of studies on proactive health services for chlamydia and gonorrhea has found that rates of presumptive treatment — antibiotics prior to laboratory test confirmation — varies widely.
Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer.
New hope for treatment of rare metabolic disease
X-linked adrenoleukodystrophy (X-ALD) is the most common of a group of around 50 rare diseases of the white matter of the brain, the so-called leukodystrophies.
Pilot study finds computer vision technology effective at determining proper mask wearing in a hospital setting
In early 2020, before COVID-19 vaccines and effective treatments were widely available, universal mask wearing was a central strategy for preventing the transmission of COVID-19. But hospitals and other settings with mask mandates faced a challenge.
Molecules found in mucus could prevent cholera infection
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause the microbe to switch into a harmful state.
UC San Diego Health Recognized for Health Equity in Care of Sickle Cell Crisis
UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals and Health Systems Quality Leaders Award in the category of health equity.
Evidence found for “substantial” monkeypox transmission before symptoms appear
A UK study published by The BMJ today found evidence for “substantial” monkeypox transmission before symptoms appear or are detected (known as pre-symptomatic transmission).
Lupus pill shows promise in mice; clinical trial underway
There’s no cure for lupus, an autoimmune disease that attacks organs. But today, scientists report they have begun phase 2 clinical trials with a pill containing a compound that, in mice, reverses organ damage and prevents death. They will present their results at ACS Fall 2022.
Used Face Masks – Infectious Waste that Requires Proper Disposal
Chula Engineering professor proposes ways to manage used masks and ATK test kits by choosing reusable masks, separating infectious waste, and preparing it properly before discarding it to be destroyed in a non-polluting disposal system to reduce overflowing waste problem.
U of U Health leads national studies of “long COVID” in adults and during pregnancy
University of Utah Health scientists are on the leading edge of a pair of large studies investigating the long-term effects of COVID-19. The nationwide studies, supported by the National Institutes of Health, will attempt to answer key questions about the lingering effects of the viral disorder on pregnant individuals and their infants, as well as why some people develop post-acute sequelae of SARS-CoV-2 (PASC), including “long COVID,” and others don’t.
What causes disease outbreaks?
Since 1974, contaminated water has been the most common driver of large-scale zoonotic infectious disease outbreaks, according to new research from the Center for the Ecology of Infectious Diseases (CEID) at the University of Georgia.
Social distancing measures in the spring of 2020 effectively curbed the COVID-19 pandemic in Germany
The measures adopted in mid-March 2020 to contain the COVID-19 pandemic both greatly reduced people’s mobility and effectively prevented the spread of COVID-19 in the following three weeks.
Former advisor to the EPA’s Office of Pesticide Program available to talk about recent EPA decisions on pesticides
In the wake of the Environmental Protection Agency’s recent release of interim decisions on glyphosate and neonicotinoids, chemicals used in agriculture that have been linked to adverse effects, Former advisor to the EPA’s Office of Pesticide Program and Clinical Professor…
Global Team Enables Child With a Fatal Genetic Disease to Recover
A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.